NEW YORK (GenomeWeb News) - Complete Genomics will sequence glioblastoma and melanoma samples for the Broad Institute as part of a pilot study the company announced last month.

For the project, Complete Genomics will use its DNA sequencing technology to sequence five samples provided by the Broad Institute. The first genome will be a sample that has already been studied extensively by the scientific community. The other four genomes will include glioblastoma and melanoma samples and their matched normal controls.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.